|
⚲
|
| AQR Innovation Fund LP - Series 8 Emerging Value Fund | |
|---|---|
| Firm |
AQR Capital Management LLC
✚
|
| Fund # | 805-4282625252 |
| CIK # | |
| Sale | |
| Fund | Hedge Fund |
| Phone | |
| Address | |
| Source | [IAPD] |
| Fund AUM and Sold ($M) |
|---|
| Fund Details | |
|---|---|
| Director | AQR Capital Management III LLC |
| Custodian | Goldman Sachs & Co LLC, JPMorgan Chase Bank National Association, JP Morgan Securities LLC |
| Auditor | PricewaterhouseCoopers |
| Marketer | |
| Broker | Goldman Sachs & Co LLC, JP Morgan Securities LLC |
| Jurisdiction |
| Comparable Firms | State | AUM ($B) |
|---|---|---|
|
Quantrx Biomedical Corp
✚
|
0.0 | |
|
Pathway Private Equity Fund V-E, LP
✚
|
0.0 | |
|
Qwest Communications International Inc
✚
|
0.0 | |
|
CO-0307 Fund I, a series of Riverside Ventures, LP
✚
|
0.0 | |
|
CO-0307 Fund I, a series of Underscore Funds, LP
✚
|
0.0 | |
|
Patton Robert J
✚
|
0.0 | |
|
Paulson DermTech Investments III, LLC
✚
|
0.0 | |
|
SLU Capital, LLC
✚
|
0.0 | |
|
Smart Michael A
✚
|
0.0 | |
|
Quantified Oncology, LLC
✚
|
0.0 |